Treatment of hyperkalaemia with intravenous salbutamol.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 2031614.
- Also identified by PMC identifier 1793005.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Thirteen children with hyperkalaemia were treated by intravenous infusions of salbutamol, 4 micrograms/kg over 20 minutes. Reductions in the mean (SD) plasma potassium concentrations, of 1.48 (0.5) and 1.64 (0.5) mmol/l were obtained at 40 and 120 minutes, respectively, after completion of the infusions. No side effects were noted.
Medical subject headings
- Albuterol
- Hyperkalemia